PN Update

October 15, 2025

News, Information, and Educational Offerings From APA

Psychiatrists are frustrated that the Make Our Children Healthy Again assessment and strategy report overlook key structural problems that are impacting children’s health—even as the documents are already helping to shape federal policy.

CLINICAL CORNER

New Consensus Criteria for Schizophrenia Relapse

Brief CBT Superior to Present-Centered Therapy at Reducing Suicide Attempts Among At-Risk Military

FDA Approves LAI Risperidone as Monotherapy or Adjunct for Maintenance Bipolar Treatment

GENERAL NEWS

Stay in the Loop With APA Membership

Autumn may have just begun, but it’s not too soon to renew your membership, so you can continue enjoying the valuable benefits APA provides—including Psychiatric News, The American Journal of Psychiatry, the APA Learning Center, reduced rates for the 2026 Annual Meeting, and much more.

Renew Today →

Acetaminophen Claims Obscure True Issues Facing Autistic Patients

Psychiatrists call the recent effort to link acetaminophen and autism misplaced and said reassurance of pregnant women and support for autistic patients and their families is needed.

Survey on Candidate DSM Biomarkers

The Future DSM Biomarkers and Biological Factors Subcommittee is surveying the field to learn about potential biomarkers and other biological factors involved in psychiatric disorders. We value your expertise in this area and welcome your input.

SUBMIT BIOMARKER OR BIOLOGICAL FACTOR →

Deadline Approaching for Two Awards

The application portals for the 2026 Distinguished Service Award and the Viswanathan Family Lifestyle Medicine and Psychiatry Award are open until October 31. Nominate yourself or a colleague today.

NOW IN PSYCHIATRIC NEWS

AI-Induced Psychosis: A New Frontier in Mental Health

After Texas Flooding, Psychiatrists Collaborate to Provide Support

The Frame Under Assault

NOW IN THE AMERICAN JOURNAL OF PSYCHIATRY

A Call for Targeted, Transdiagnostic Approaches to Premenstrual Disorders

Neural Predictors of Risk for Developing a Depressive Disorder

October Editor Spotlight

Deputy Editor Danny Pine reviews the safety data for esketamine over the five years since FDA approval and the associations between structural brain development and onset of depression during adolescence and emerging adulthood.

NOW IN PSYCHIATRIC SERVICES

Trauma Interventions in Schools: Assessing the Evidence Base

The Enduring Relevance of General Systems Theory to Community Psychiatry

Equity-Centered Trauma-Informed Educational Initiatives in Schools

Editor’s Choice Collection: Community Correctional Care

Copyright © 2025 {{ site_settings.company_name }}. All rights reserved.
{{ site_settings.company_street_address_1 }}, {{ site_settings.company_street_address_2 }}, {{ site_settings.company_city }}, {{ site_settings.company_state }}, {{ site_settings.company_zip }},{{ site_settings.company_country }}, {{ site_settings.company_phone }}

Unsubscribe Manage Preferences

Important information: You are receiving this correspondence because you previously requested to receive information via email. Please do not reply to this email, as we are unable to respond to messages sent to this address. You can send your comments or questions to PNUpdate@psych.org. The content of Psychiatric News does not necessarily reflect the views of APA or the editors. Unless so stated, neither Psychiatric News nor APA guarantees, warrants, or endorses information or advertising on this site. Clinical information is not peer reviewed and thus should be independently verified. Privacy Policy.